BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pabjan P, Brzdęk M, Chrapek M, Dziedzic K, Dobrowolska K, Paluch K, Garbat A, Błoniarczyk P, Reczko K, Stępień P, Zarębska-Michaluk D. Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals? Viruses 2022;14:96. [PMID: 35062302 DOI: 10.3390/v14010096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie J, Xu B, Wei L, Huang C, Liu W. Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis. Infect Dis Ther 2022. [PMID: 35749010 DOI: 10.1007/s40121-022-00666-0] [Reference Citation Analysis]
2 Flisiak R, Zarębska-Michaluk D, Flisiak-Jackiewicz M. Ways to Eliminate Viral Hepatitis as a Global Health Threat. Viruses 2022;14:1554. [PMID: 35891534 DOI: 10.3390/v14071554] [Reference Citation Analysis]
3 Cheng CY, Ku SY, Lin YC, Chen CP, Cheng SH, Lin IF. Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV. Viruses 2022;14:439. [PMID: 35216032 DOI: 10.3390/v14020439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]